康恩贝：关于子公司艾司奥美拉唑镁肠溶胶囊获得药品注册证书的公告

Group 1 - The company announced that its wholly-owned subsidiary, Zhejiang Jinhua Kang En Bei Biological Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the registration of 20mg and 40mg specifications of Esomeprazole Magnesium Enteric-coated Capsules, which is considered equivalent to passing the consistency evaluation for generic drugs [2] - The company has invested approximately 12.4 million yuan in research and development for this product [2] - The product is classified as a Category B drug under medical insurance, with an estimated domestic sales revenue of 815 million yuan for similar capsules in 2024 [2]